InvestorsHub Logo
Followers 6
Posts 601
Boards Moderated 0
Alias Born 09/05/2013

Re: robertmaxwell post# 10984

Friday, 12/15/2017 3:42:32 PM

Friday, December 15, 2017 3:42:32 PM

Post# of 12137
Nice find Robert, it would appear we may want to keep our rev expectations on the low end this quarter. Fda approvals are one thing, insurance coverage is a whole different game. Im assuming novartis will run into a similar issue initially.

We can hope the 21st Century Cures Act will help cut initial costs of new treatments so more people benefit sooner, and not have to pass away while waiting for the geen light from insurance...especially children!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYRX News